64 percent Indians confident with two doses of COVID vaccine, not interested in precautionary dose: Survey

Published On 2022-07-08 09:35 GMT   |   Update On 2022-07-08 09:35 GMT
Advertisement

YouGov's latest survey reveals the sentiments of urban Indians towards the booster dose of coronavirus.

Many people who have had both doses of the vaccine are inclined to take the booster dose, but when considering those who do not wish to do so, a majority (64 per cent of respondents) tells that their confidence in the two doses of the vaccine is the most important factor for not wanting a precautionary dose. Close to one in five (19 per cent) stated that they are scared of the short-term side-effects like fever, etc while 17 percent are worried about the alleged long-term side effects of the vaccines (like heart attacks, medical complications, etc). Some doubt the effectiveness of the booster dose (15 percent) while others (13 percent) said they took the first dose of out compulsion (for travel, etc) but will now resist taking a booster dose for Covid.

For more news, check out the medical dialogues:

https://medicaldialogues.in/ 


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News